Related references
Note: Only part of the references are listed.Genetic Susceptibility to Atherosclerosis
Sanja Kovacic et al.
STROKE RESEARCH AND TREATMENT (2012)
Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine
Johannes Jacobi et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population
Cheng-Chieh Lin et al.
BMC PUBLIC HEALTH (2010)
A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change
L. Maria Belalcazar et al.
DIABETES CARE (2010)
Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study
J. Saltevo et al.
DIABETIC MEDICINE (2008)
Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women
Sabina Cauci et al.
OBSTETRICS AND GYNECOLOGY (2008)
Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2
Kazuhiro Hasegawa et al.
CIRCULATION RESEARCH (2007)
Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes
ES Kang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Association of C-reactive protein with blood pressure and hypertension - Life course confounding and Mendelian randomization tests of causality
GD Smith et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
C-reactive protein
S Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency - A randomized, controlled clinical trial
G Sesmilo et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
